Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

Lieneke F.M. Ariens; Jorien van der Schaft; Aline M.E. Stades; Anthonie A. van de Woestijne; Marjolein S. De Bruin-Weller

doi:10.2340/00015555-2936

Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

Lieneke F.M. Ariens, Jorien van der Schaft, Aline M.E. Stades, Anthonie A. van de Woestijne, Marjolein S. De Bruin-Weller

Research output: Contribution to journal › Editorial › Academic › peer-review

4 Downloads (Pure)

Original language	English
Pages (from-to)	601-602
Number of pages	2
Journal	Acta Dermato-Venereologica
Volume	98
Issue number	6
DOIs	https://doi.org/10.2340/00015555-2936
Publication status	Published - 8 Jun 2018

Keywords

Administration, Cutaneous
Adrenal Cortex Hormones/administration & dosage
Adrenal Insufficiency/blood
Antibodies, Monoclonal/therapeutic use
Antibodies, Monoclonal, Humanized
Betamethasone/administration & dosage
Biomarkers/blood
Dermatitis, Atopic/diagnosis
Drug Substitution/adverse effects
Humans
Hydrocortisone/administration & dosage
Male
Middle Aged
Remission Induction
Severity of Illness Index
Treatment Outcome

Access to Document

10.2340/00015555-2936Licence: CC BY-NC

ariensFinal published version, 495 KBLicence: CC BY-NC

Cite this

Ariens, L. F. M., van der Schaft, J., Stades, A. M. E., van de Woestijne, A. A., & De Bruin-Weller, M. S. (2018). Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids. Acta Dermato-Venereologica, 98(6), 601-602. https://doi.org/10.2340/00015555-2936

@article{cfee47e6356a4cb9b1eb3435670b36f0,

title = "Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids",

keywords = "Administration, Cutaneous, Adrenal Cortex Hormones/administration & dosage, Adrenal Insufficiency/blood, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal, Humanized, Betamethasone/administration & dosage, Biomarkers/blood, Dermatitis, Atopic/diagnosis, Drug Substitution/adverse effects, Humans, Hydrocortisone/administration & dosage, Male, Middle Aged, Remission Induction, Severity of Illness Index, Treatment Outcome",

author = "Ariens, {Lieneke F.M.} and {van der Schaft}, Jorien and Stades, {Aline M.E.} and {van de Woestijne}, {Anthonie A.} and {De Bruin-Weller}, {Marjolein S.}",

note = "Funding Information: The patient described in this case report participated in 2 phase III dupilumab clinical trials sponsored by Regeneron.",

year = "2018",

month = jun,

day = "8",

doi = "10.2340/00015555-2936",

language = "English",

volume = "98",

pages = "601--602",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

number = "6",

}

Ariens, LFM, van der Schaft, J, Stades, AME, van de Woestijne, AA & De Bruin-Weller, MS 2018, 'Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids', Acta Dermato-Venereologica, vol. 98, no. 6, pp. 601-602. https://doi.org/10.2340/00015555-2936

Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids. / Ariens, Lieneke F.M.; van der Schaft, Jorien; Stades, Aline M.E. et al.
In: Acta Dermato-Venereologica, Vol. 98, No. 6, 08.06.2018, p. 601-602.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis

T2 - Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

AU - Ariens, Lieneke F.M.

AU - van der Schaft, Jorien

AU - Stades, Aline M.E.

AU - van de Woestijne, Anthonie A.

AU - De Bruin-Weller, Marjolein S.

N1 - Funding Information: The patient described in this case report participated in 2 phase III dupilumab clinical trials sponsored by Regeneron.

PY - 2018/6/8

Y1 - 2018/6/8

KW - Administration, Cutaneous

KW - Adrenal Cortex Hormones/administration & dosage

KW - Adrenal Insufficiency/blood

KW - Antibodies, Monoclonal/therapeutic use

KW - Antibodies, Monoclonal, Humanized

KW - Betamethasone/administration & dosage

KW - Biomarkers/blood

KW - Dermatitis, Atopic/diagnosis

KW - Drug Substitution/adverse effects

KW - Humans

KW - Hydrocortisone/administration & dosage

KW - Male

KW - Middle Aged

KW - Remission Induction

KW - Severity of Illness Index

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85048507728&partnerID=8YFLogxK

U2 - 10.2340/00015555-2936

DO - 10.2340/00015555-2936

M3 - Editorial

C2 - 29881868

AN - SCOPUS:85048507728

SN - 0001-5555

VL - 98

SP - 601

EP - 602

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 6

ER -

Ariens LFM, van der Schaft J, Stades AME, van de Woestijne AA, De Bruin-Weller MS. Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids. Acta Dermato-Venereologica. 2018 Jun 8;98(6):601-602. doi: 10.2340/00015555-2936

Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

Keywords

Access to Document

Other files and links

Cite this